About us

Discover who we are and what we value

Innovating blood-based cancer mutation detection

We’re Sysmex Inostics, the molecular diagnostics company that pioneered blood-based circulating tumor DNA oncology testing with highly sensitive technologies, including BEAMing and Plasma Sequencing. Our goal is to help detect gene mutations in cancer quickly and accurately, and allow physicians to adopt targeted therapies earlier to better monitor disease response and recurrence.

The Sysmex Way

The Sysmex Way represents who we are, and how we want to act. A core feature of the Sysmex Way is trust. Clients can trust that our products and solutions have undergone rigorous testing and validation to solve the most difficult clinical challenges.

We’re confident in our abilities. Employees are given broad scope for decision-making. Experience teaches us that having confidence in our employees translates into close involvement with the company – a great, mutually-reinforcing circle.

We greatly appreciate teamwork and the remarkable diversity and creativity generated by simply letting people be who they really are.


Shape the advancement of healthcare


Create unique and innovative value, while building trust and confidence


Demonstrate our individual competence and unsurpassed teamwork with passion and flexibility

Our facilities

We have a CLIA-certified laboratory in Baltimore, Maryland and a GCP laboratory in Hamburg, Germany. We also provide testing services in China and Japan. Our OncoBEAM™ assays are offered through laboratories that participate in our Centers of Excellence program in Europe, Asia Pacific and Latin America.

What we offer

As a subsidiary of Sysmex Corporation, we’re a trusted partner to leading physicians and pharmaceutical companies. We advance their efforts to bring the most effective personalized cancer therapies to global markets.

Request more information

Get answers to your questions about OncoBEAM™

Company news

Read the latest news on Sysmex Inostics and OncoBEAM™